Page 23 - Read Online
P. 23

Page 4 of 10             Onishi et al. Plast Aesthet Res 2024;11:5  https://dx.doi.org/10.20517/2347-9264.2023.102























                Figure 1. Schematic drawing of the surgical planning of LVA for upper extremity lymphedema. LVA targets the linear-visualized
                lymphatic vessels or those with dermal backflow, if present. LVA: lymphaticovenous anastomosis.

               To compare the two groups, the Wilcoxon rank-sum test was performed for continuous data, and the chi-
               square or Fisher's exact test for categorical data. All tests were two-tailed, and statistical significance was
               defined as P < 0.05. Standardized mean differences were calculated. All analyses were performed using
               EZR , a graphical user interface software for R (version 3.6.3; R Foundation for Statistical Computing,
                   [7]
               Vienna, Austria).


               RESULTS
               All 50 patients were clinically classified as having stage II disease. Of these, 28 patients underwent LVA
               within 6 months of CDT initiation, whereas 22 patients underwent LVA > 6 months after CDT initiation
               [Table 1]. The stratified number of LVA cases per 2-year period over the study duration is shown in
               Figure 2.


               All patients received CDT from the same trained therapist. Postoperative compression was individualized.
               Preoperatively, 10 Early Group patients (36%) wore Class 0 compression garments, 2 (7%) Class 1, and 16
               (57%) Class 2. Among Non-early Group, 4 (18%) used Class 0, 1 (7.1%) Class 1, and 17 (77.3%) Class 2.
               Postoperatively, 6 Early Group patients (21.4%) wore Class 0, 4 (14.3%) Class 1, and 18 (64.3%) Class 2
               compression. In the Non-early group postoperatively, 6 (27.3%) wore Class 0, 1 (4.5%) Class 1, and 15
               (68.2%) Class 2. No significant differences were seen between the two groups both preoperatively
               and postoperatively [Table 2]. The primary outcomes were postoperative PEV and the reduction rate
               at  12 months.  The  results  showed  that,  after  applying  overlap  weighting,  the  baseline
               characteristics and demographics of the treatment and control groups were balanced [Table 2]. At the 12-
               month postoperative follow-up, the early treatment group had a significantly lower PEV of 4% compared
               with 10% in the delayed treatment  group  (P  =  0.02)  [Figure 3]. This  difference  corresponds  to  a
               medium  effect  size,  with  a standardized  mean  difference  (SMD)  of  0.42.  Additionally,  the  early
               treatment  group  had  a  significantly greater  reduction  rate  of  56%  compared  to  25%  in  the  delayed
               treatment group (P = 0.03) [Figure 4]. The reduction rate difference also represented a medium effect size,
               with an SMD of 0.59 [Table 2].

               Representative cases
               Case 1: A 52-year-old woman presented with lymphedema of the left upper extremity [Figure 5A]. CDT
               started 1 month after the onset of lymphedema, and LVA surgery was performed after four months of CDT
               management. The postoperative picture showed marked improvement of the edema in the affected limb
               [Figure 5B].
   18   19   20   21   22   23   24   25   26   27   28